Jane Skeen

1.2k total citations
17 papers, 442 citations indexed

About

Jane Skeen is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Oncology. According to data from OpenAlex, Jane Skeen has authored 17 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Jane Skeen's work include Childhood Cancer Survivors' Quality of Life (7 papers), Renal and related cancers (6 papers) and Family Support in Illness (4 papers). Jane Skeen is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (7 papers), Renal and related cancers (6 papers) and Family Support in Illness (4 papers). Jane Skeen collaborates with scholars based in New Zealand, Australia and United States. Jane Skeen's co-authors include D. M. O. Becroft, Ian M. Morison, A E Reeve, Osamu Ogawa, Michael R. Eccles, Richard J. Cohn, Anthony E. Reeve, Jordana K. McLoone, Claire E. Wakefield and Joanna E. Fardell and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Cancer.

In The Last Decade

Jane Skeen

17 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane Skeen New Zealand	11	241	198	109	101	92	17	442
Gail Megason United States	12	119 0.5×	82 0.4×	51 0.5×	34 0.3×	23 0.3×	34	425
Natasha K. A. van Eijkelenburg Netherlands	13	143 0.6×	84 0.4×	110 1.0×	40 0.4×	20 0.2×	38	444
Jean Fergusson United States	7	282 1.2×	76 0.4×	215 2.0×	65 0.6×	16 0.2×	15	522
Ray Pais United States	9	187 0.8×	46 0.2×	122 1.1×	74 0.7×	24 0.3×	13	530
A. Overbeek Netherlands	17	220 0.9×	93 0.5×	536 4.9×	39 0.4×	45 0.5×	32	784
Roger A. Vega United States	9	148 0.6×	52 0.3×	90 0.8×	52 0.5×	20 0.2×	14	349
Amy E. French Canada	8	151 0.6×	37 0.2×	143 1.3×	42 0.4×	19 0.2×	9	397
Ueli Caflisch Switzerland	9	176 0.7×	44 0.2×	125 1.1×	42 0.4×	45 0.5×	11	327
Kelly K. Sawczyn United States	11	170 0.7×	75 0.4×	204 1.9×	74 0.7×	9 0.1×	17	488
Belinda Rahman Australia	13	115 0.5×	101 0.5×	128 1.2×	37 0.4×	434 4.7×	27	633

Countries citing papers authored by Jane Skeen

Since Specialization

Citations

This map shows the geographic impact of Jane Skeen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Skeen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Skeen more than expected).

Fields of papers citing papers by Jane Skeen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Skeen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Skeen. The network helps show where Jane Skeen may publish in the future.

Co-authorship network of co-authors of Jane Skeen

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Skeen. A scholar is included among the top collaborators of Jane Skeen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Skeen. Jane Skeen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Fardell, Joanna E., Claire E. Wakefield, Richard De Abreu Lourenço, et al.. (2021). Long‐term health‐related quality of life in young childhood cancer survivors and their parents. Pediatric Blood & Cancer. 68(12). e29398–e29398. 32 indexed citations

Ekeroma, Alec, R. E. Dyer, Neal A. Palafox, et al.. (2019). Cancer management in the Pacific region: a report on innovation and good practice. The Lancet Oncology. 20(9). e493–e502. 19 indexed citations

Signorelli, Christina, Claire E. Wakefield, Jordana K. McLoone, et al.. (2019). Childhood cancer survivorship: barriers and preferences. BMJ Supportive & Palliative Care. 12(e5). e687–e695. 24 indexed citations

Tonorezos, Emily S., Dana Barnea, Richard J. Cohn, et al.. (2018). Models of Care for Survivors of Childhood Cancer From Across the Globe: Advancing Survivorship Care in the Next Decade. Journal of Clinical Oncology. 36(21). 2223–2230. 71 indexed citations

Ballantine, Kirsten, Susan S. Hanna, Scott Macfarlane, et al.. (2018). Childhood cancer registration in New Zealand: A registry collaboration to assess and improve data quality. Cancer Epidemiology. 55. 104–109. 2 indexed citations

Fukuzawa, Ryuji, David Markie, Richard G. Grundy, et al.. (2018). Germline mutations and somatic inactivation of TRIM28 in Wilms tumour. PLoS Genetics. 14(6). e1007399–e1007399. 34 indexed citations

Fardell, Joanna E., Claire E. Wakefield, Christina Signorelli, et al.. (2018). Attitudes and experiences of childhood cancer survivors transitioning from pediatric care to adult care. Supportive Care in Cancer. 26(8). 2743–2750. 29 indexed citations

Brock, Penelope, Margaret Childs, Kaukab Rajput, et al.. (2016). Two-year results of clinical efficacy of cisplatin in combination with sodium thiosulfate (STS) vs cisplatin alone in a randomized phase III trial for standard risk hepatoblastoma (SR-HB): SIOPEL 6.. Journal of Clinical Oncology. 34(15_suppl). 10514–10514. 7 indexed citations

Brock, Penelope, Rudolf Maibach, Margaret Childs, et al.. (2015). Anti-tumor efficacy in SIOPEL 6: A multi-centre open label randomised phase III trial of the efficacy of sodium thiosulphate (STS) in reducing ototoxicity in patients receiving cisplatin (Cis) monotherapy for standard risk hepatoblastoma (SR-HB).. Journal of Clinical Oncology. 33(15_suppl). 10039–10039. 1 indexed citations

10.

Maibach, Rudolf, Margaret Childs, Kaukab Rajput, et al.. (2014). SIOPEL 6: A multicenter open-label randomized phase III trial of the efficacy of sodium thiosulphate (STS) in reducing ototoxicity in patients receiving cisplatin (Cis) monotherapy for standard-risk hepatoblastoma (SR-HB).. Journal of Clinical Oncology. 32(15_suppl). TPS10094–TPS10094. 7 indexed citations

11.

Li, Wenliang, Patricia Kessler, Herman Yeger, et al.. (2005). A Gene Expression Signature for Relapse of Primary Wilms Tumors. Cancer Research. 65(7). 2592–2601. 46 indexed citations

12.

Smibert, Elizabeth, et al.. (2005). Prospective audit of treatment of paediatric febrile neutropenia in Australasia. Journal of Paediatrics and Child Health. 41(11). 598–603. 14 indexed citations

13.

Rapley, Elizabeth, Rita Barfoot, Catherine Bonaïti‐Pellié, et al.. (2000). Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2. British Journal of Cancer. 83(2). 177–183. 33 indexed citations

14.

Becroft, D. M. O., John D. Dockerty, Margaret E. Lewis, et al.. (1999). Childhood cancer in new zealand 1990 to 1993. Pathology. 31(2). 83–89. 10 indexed citations

15.

Becroft, D. M. O., et al.. (1995). Good Prognosis of Cellular Mesoblastic Nephroma with Hyperdiploidy and Relaxation of Imprinting of the Maternal IGF2 Gene. Pediatric Pathology & Laboratory Medicine. 15(5). 679–688. 10 indexed citations

16.

Ogawa, Osamu, D. M. O. Becroft, Ian M. Morison, et al.. (1993). Constitutional relaxation of insulin–like growth factor II gene imprinting associated with Wilms' tumour and gigantism. Nature Genetics. 5(4). 408–412. 92 indexed citations

17.

Ridgway, Derry, et al.. (1991). Childhood cancer among the polynesian population. Cancer. 68(2). 451–454. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact